Natural Biocon Faces Steep Revenue Fall, Auditor Flags Governance Issues

Natural Biocon (India) Ltd has reported a stark financial performance for fiscal year 2026 (FY26), with revenues plummeting 69.51% year-on-year to ₹2.55 Cr from ₹8.35 Cr in the previous year. The company posted a net loss of ₹0.04 Cr for the full fiscal year.

While the company achieved a narrower net loss of ₹0.09 Cr in the fourth quarter of FY26 (compared to ₹0.49 Cr in Q4 FY25), this improvement was overshadowed by the significant annual revenue contraction. Q4 FY26 standalone revenue was ₹0.88 Cr, down 34.90% from the same period last year.

Auditor's Report Highlights Critical Concerns

Adding to the financial pressure, the statutory auditor's report has identified several critical issues impacting the company's governance and financial transparency. A key concern is the utilization of ₹19.45 Cr raised through a preferential allotment, which the auditor noted was used for investments instead of the declared working capital purposes.

The auditor also flagged substantial difficulties in verifying the company's investments due to the non-provision of share certificates or demat statements. Further concerns include non-compliance with dividend payment obligations, outstanding unpaid dividends, and delays in receiving confirmations for debit and credit balances from various counterparties.

These findings emerged as the auditor, M/s Mayur Shah & Associates, formally attempted to resign on February 14, 2026. The company's management has not accepted this resignation, leaving the situation unresolved and increasing uncertainty about future audits.

Impact and Future Focus

The combination of a dramatic revenue fall and serious auditor-flagged issues is expected to lead to heightened scrutiny of Natural Biocon's operations and financial reporting. Investors will be closely watching management's response to the auditor's findings and any corrective actions taken. Potential regulatory action from SEBI or stock exchanges regarding disclosures and compliance is also a factor investors will monitor, alongside the company's efforts to clarify the use of raised funds and resolve the auditor situation.

Peer Comparison

Identifying direct listed peers for Natural Biocon (India) Ltd is challenging due to its very small operational scale. While the company operates within the specialty chemicals and intermediates sector, which has numerous participants, direct comparisons remain limited.